← All diseases

Disease Atlas / Disease detail

Precocious Puberty

This is educational material that provides an easy-to-understand summary of the definition, causes, symptoms, diagnosis, management, and research issues of precocious puberty.

precocious puberty

MONDO:0000088Public QA completeSource-bound · 1

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · d11bc529af8b

Disease Category
Precocious puberty refers to a condition where secondary sexual characteristics appear earlier than the typical onset of puberty.
Core mechanism
Causes can be divided into cases where puberty signals are activated early in the brain and cases where sex hormones increase due to other causes, and in some cases, no clear cause is found.
Main causes · Related factors
If the hypothalamus-pituitary-gonadal axis is activated early or if sex hormones increase independently, growth and secondary sexual characteristics may be accelerated.
Representative patterns
Representative manifestations include breast development, appearance of pubic or axillary hair, growth of the testes and penis, body odor and acne, and rapid height growth.
Individual differences
The likelihood and course may vary depending on sex, family history, weight and growth patterns, central nervous system disease or injury, and exposure to certain medications or hormones.
Diagnosis
In the early stages, the growth rate may accelerate, but accelerated bone maturation can affect final height, and the rate of progression and psychological burden vary from person to person.
Management
Diagnostic evaluation is conducted by assessing bone age and sex hormone levels based on growth records and physical examinations, and if necessary, by combining stimulation tests and imaging studies.
Treatment/Research Status
It is difficult to make a determination based on a single test or physical sign alone; to distinguish between normal individual variation and rapidly progressing puberty, changes over time and the clinical context of examinations must be considered together.
Evidence Reading
Management is carried out by determining whether to observe or treat by considering the cause, rate of progression, bone maturity, growth prognosis, and psychosocial impact together.
Key Precautions
In central precocious puberty, GnRH agonist treatment to delay puberty progression may be considered, but it is not necessary for everyone, and an approach based on the cause and pattern of progression is important.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a Glance

Precocious puberty refers to a condition where secondary sexual characteristics appear earlier than the typical onset of puberty.

Representative manifestations include breast development, appearance of pubic or axillary hair, growth of the testes and penis, body odor and acne, and rapid height growth.

How the Disease Works

Causes can be divided into cases where puberty signals are activated early in the brain and cases where sex hormones increase due to other causes, and in some cases, no clear cause is found.

If the hypothalamus-pituitary-gonadal axis is activated early or if sex hormones increase independently, growth and secondary sexual characteristics may be accelerated.

Patterns Vary by Person

The likelihood and course may vary depending on sex, family history, weight and growth patterns, central nervous system disease or injury, and exposure to certain medications or hormones.

Broad framework of diagnosis and management

In the early stages, the growth rate may accelerate, but accelerated bone maturation can affect final height, and the rate of progression and psychological burden vary from person to person.

Diagnostic evaluation is conducted by assessing bone age and sex hormone levels based on growth records and physical examinations, and if necessary, by combining stimulation tests and imaging studies.

Current stage of treatment

It is difficult to make a determination based on a single test or physical sign alone; to distinguish between normal individual variation and rapidly progressing puberty, changes over time and the clinical context of examinations must be considered together.

Management is carried out by determining whether to observe or treat by considering the cause, rate of progression, bone maturity, growth prognosis, and psychosocial impact together.

In central precocious puberty, GnRH agonist treatment to delay puberty progression may be considered, but it is not necessary for everyone, and an approach based on the cause and pattern of progression is important.

How to read clinical trials

In follow-up, height growth rate, changes in sexual characteristics, bone age, and response to treatment are repeatedly evaluated, and effectiveness or whether standard treatment is required should not be determined solely by registration or progress in clinical trials.

Points to verify in clinical encounters

In clinical practice, it is helpful to assess the timing of the onset of secondary sexual characteristics and the rate of change, growth records, medications and hormone exposure, neurological symptoms, family history, purpose of examination, and follow-up plans.

Medical Guide

This material is for educational purposes and does not replace individual diagnosis or treatment. Please consult with medical professionals for judgment on symptoms or test results and for treatment decisions.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.